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Primary adenocarcinoma ofthe duodenum is a rare tumourwhich accountsfor
less than 0.5% of intestinal malignancies 1,2, and the optimum treatment is
unknown. PrevioussurgicaltreatmenthasconsistedofWhippletypepancreatico-
duodenectomy or segmental resection , while chemotherapy has been
confinedtopurelypalliativecases3'6'7. Inpancreaticdiseases, pyloruspreserving
pancreatico-duodenectomy appears to offer advantages over the classical
Whipple procedure 8,9. However, there are few reported cases employing this
operation in duodenal carcinoma'0, and there are no reports of the efficacy of
chemotherapy to improve prognosis following potentially curative surgery.
Case 1. A 64 yearold male presented with symptoms and signs in keepingwith
gastric outlet obstruction. Barium meal revealed a stricture, suggestive of a
tumour, in the third partofthe duodenum (Figure). CT scan confirmed this and
revealednoevidenceofmetastasis (Figure). Laparotomyconfirmedastenosing
tumour of the third part of the duodenum. Intra-operative ultrasonography
revealed noevidence ofhepatic metastases. Apylorus preserving pancreatico-
duodenectomywasperformedandthepatientmadeanuneventfulpostoperative
recovery. Histological examination identified a primary duodenal
adenocarcinoma with involvement of two local lymph nodes. Four courses of
adjuvant chemotherapy, consisting of 5-fluorouracil, cisplatin, epirubicin and
folinic acidweregiven, withoutsignificantcomplication. Therewasnoevidence
of ascites or recurrence on ultrasound scan at one year and he remains well 24
months following surgery.
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Fig. Barium meal and CT scan demonstrating a stricture in the third part of the duodenum
(arrow) due to a 4 cm diameter solid lesion (seen between calipers).
Case2. A 40 year old male presented with a two yearhistory ofepigastric pain,
anorexia and weight loss, which had persisted despite long-term anti-ulcer
medication. Endoscopy revealed an ulcerating lesion in the third part of the
duodenum andbiopsyidentifiedthis as an adenocarcinoma. CTscan confirmed
thepresenceofaduodenallesion butrevealednometastaticspread. Laparotomy
confirmed a tumour of the third part of the duodenum with involvement of the
transverse mesocolon. Intra-operative ultrasonography revealed no evidence
of hepatic metastases. He underwent pylorus preserving pancreatico-
duodenectomyandextendedrighthemicolectomy. Postoperativelyhedeveloped
delayed gastric emptying which resolved spontaneously after one week.
Histological examination revealed a primary duodenal adenocarcinoma with
extension to the serosa but without lymph node involvement. He received four
courses ofchemotherapy (5-fluorouracil, cisplatin, epirubicin andfolinic acid),
without significant complication. He remains well 12 monthsfollowing surgery.
DISCUSSION
Primary duodenal carcinoma is rare, accounting for 0.03 to 0.35% of all
intestinal malignancies" 2. The proportion of lesions occurring in the 1st, 2nd,
3rd and 4th parts of the duodenum is 45%, 35%, 10% and 10%, respectively".
Tumours of the third part, are extremely uncommon'2. Only 89 cases of infra-
papillary duodenal carcinoma were cited in the literature from 1961-745 "l, but
duodenal carcinoma represents 25-48% of primary tumours of the small
intestine6' 13. The average age at presentation is sixty years, male tofemale ratio
3:11. There is no racial predilection'4.
Symptoms associated with duodenal carcinoma are abdominal pain, weight
loss (each present in 74% of cases), vomiting and anaemia (each present in
55% of patients)'5. These symptoms are non-specific, the clinical picture often
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mimicking peptic ulceration. However, as in our second case, there is failure to
respond to ulcer healing medication. This emphasises the importance of
considering rarer diagnoses, such as duodenal carcinoma, in cases where
symptoms persist despite standard upper gastrointestinal investigation and
anti-ulcertreatment. Latepresentations includebiliaryobstructionwithjaundice
or an abdominal mass6' 16. The absence of specific symptoms and signs,
coupled with the rarity of the condition, means that diagnosis is frequently
delayed. The average time to correct diagnosis from initial consultation is
between 7-10 months6"17 - in one of our cases, symptoms were present for two
years before a definitive diagnosis was made. Consequently, a high index of
suspicion is essential if the condition is to be recognised early.
Even with early referral, investigations may fail to make the diagnosis, thus
making recognition difficult. Barium studies may not detect small tumours in
the third part ofthe duodenum, since special posturing is necessary to visualise
this region". The accuracy of barium studies in this area is, therefore, 75% or
less4. Barium studies are particularly valuable in lesions ofthe fourth partofthe
duodenum, which are often not reached by endoscopy. In general, however,
duodenoscopy ispreferabletobariumstudies, asitallowsbothdirectvisualisation
and biopsy of the lesion. Failure to visualise the distal part of the duodenum
limits the reported sensitivity to 89%7, thus emphasising the importance of
distal duodenoscopy during routine upper gastrointestinal endoscopy. We
found computerised tomography and intraoperative ultrasonography useful in
assessing local or distant spread, and therefore of benefit in determining the
potential for curative resection of the tumour 18.
The preferred surgical procedure for treatment of distal duodenal carcinoma
remains to be determined. Surgical options include palliative bypass,
pancreatico-duodenectomy and local segmental resection. Although one
seriesreported a significantly differentsurvival atoneyearbetween pancreatico-
duodenectomy and segmental resection (62% versus 45%, respectively), this
was not maintained atfive years (25% versus 20%)5. The lownumberofpatients
surviving five years probably explains this finding. Segmental resection is
associated with a higher incidence of recurrence due to the limited resection of
regional lymphatic and adjacent tissue 3. The technique may still have a place
in high risk patients or in patients with very small lesions, where satisfactory
tumour clearance can be achieved with a tension free anastomosis. However,
since regional spread is frequently encountered, radical surgery offers the best
chance of cure. Pancreatico-duodenectomy is therefore recommended.3 4' 5
Admittedly there is patient selection, but the five year survival following
pancreatico-duodenectomy is 40-45%, compared to the overall five year
survival for duodenal carcinoma of 5-17% 35.6 19. 2O. In pancreatic carcinoma,
pylorus preserving pancreatico-duodenectomy is claimed to be easier, less
time consuming and associated with less blood loss, a shorterhospital stay and
better weight gain than the classical Whipple procedure9. In addition, the
incidence of dumping, diarrhoea and enterogastric reflux are lower 20. Claims
that this operation is complicated by transient delayed gastric emptying and
marginal ulceration more frequently than in the Whipple procedure have not
been substantiated 21 22. Isotope studies have shown that delayed gastric
emptyingis common in both procedures, there being no significant difference
in emptying ofboth liquids and solids between both techniques22. In one of our
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cases, a delay in gastric emptying occurred butthiswas transient and resolved
within one week. The advantages of pylorus preservation therefore, appear to
outweigh the disadvantages and it seems logical to apply this technique to
distal duodenal carcinomas.
Experiencewith adjuvantchemotherapy in duodenal carcinoma isalsolimited.
Previous reports have restricted chemotherapy to purely palliative cases.
Results inthese poorprognosis patients havebeenpromising, witha significant
improvement in mean survival 3'4.67,11,3. It is also suggestedthat postoperative
palliative treatment with combined chemo-radiotherapy is associated with a
bettersurvival than that obtained by surgery alone'13,. Chemotherapy should,
therefore, prove beneficial in better prognosis cases. In ourlimited experience,
thecombinationofpyloruspreservingpancreatico-duodenectomy andadjuvant
chemotherapy iswelltolerated. Combiningadjuvantchemotherapywithpylorus
preserving pancreatico-duodenectomy should, theoretically, provide the
maximal chance of cure without significant increase in side effects.
Survival in duodenal carcinoma is related to the extent oftumour spread. The
lack of specific symptoms results in two thirds of patients presenting with
metastases, 32% having paraduodenal and 33-67% regional nodal
involvement 5,'7,23. One of our cases had local nodal involvement. Median
survival for cases without metastases and those with paraduodenal or regional
nodal involvement is42, 16 and 6 months, respectively 23. The overall survival
is generally poor, being 67% at one year and 5-17% atfive years 5 6, Even after
potentially curative resection, five yearsurvival rarely exceeds 15-25%6. Infra-
papillary tumours are thought to be associated with a better prognosis than
supra-papillary lesions, the mean survival being 31-46 months compared to
27- 30 months, respectively 6,12.
We believe that combined modality treatment has a definitive role in the
treatmentofpotentially curative cases ofdistal duodenal carcinoma. The rarity
ofthe condition means that, even with longer follow-up, no single unit will see
sufficient cases to draw conclusions or develop formalised guidelines on
treatment. A prospective multicentre trial of this condition is required.
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